Published in Antimicrob Agents Chemother on December 01, 2005
Efflux-mediated drug resistance in bacteria: an update. Drugs (2009) 3.18
Genetic elements responsible for erythromycin resistance in streptococci. Antimicrob Agents Chemother (2008) 1.79
Diversity and mobility of integrative and conjugative elements in bovine isolates of Streptococcus agalactiae, S. dysgalactiae subsp. dysgalactiae, and S. uberis. Appl Environ Microbiol (2010) 1.05
New genetic element carrying the erythromycin resistance determinant erm(TR) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.97
DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci. Antimicrob Agents Chemother (2006) 0.97
Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates. J Clin Microbiol (2014) 0.89
Molecular epidemiology of macrolide and tetracycline resistances in commensal Gemella sp. isolates. Antimicrob Agents Chemother (2007) 0.82
Transduction of the Streptococcus pyogenes bacteriophage Φm46.1, carrying resistance genes mef(A) and tet(O), to other Streptococcus species. Front Microbiol (2015) 0.78
Decline and rise of the antimicrobial susceptibility of Streptococcus pneumoniae isolated from middle ear fluid in children: influence of changes in circulating serotypes. Antimicrob Agents Chemother (2012) 0.77
Conjugative transfer of resistance determinants among human and bovine Streptococcus agalactiae. Braz J Microbiol (2014) 0.76
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep (2002) 6.51
Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis (2002) 6.03
Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev (1998) 5.36
Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol (1996) 4.86
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 4.38
Group B streptococcal disease in nonpregnant adults. Clin Infect Dis (2001) 3.22
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother (2001) 2.30
Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J Clin Microbiol (2002) 2.23
Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 2.21
A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother (1999) 2.04
Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. J Infect Dis (2001) 1.79
Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J Clin Microbiol (2002) 1.71
Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 1.71
Use of Granada medium to detect group B streptococcal colonization in pregnant women. J Clin Microbiol (1999) 1.64
Presence of mefA and mefE genes in Streptococcus agalactiae. Antimicrob Agents Chemother (1999) 1.64
Tn2009, a Tn916-like element containing mef(E) in Streptococcus pneumoniae. Antimicrob Agents Chemother (2004) 1.52
Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus. J Infect Dis (2003) 1.49
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother (2003) 1.34
Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother (2001) 1.32
Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates. J Clin Microbiol (2001) 1.29
Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. J Antimicrob Chemother (2004) 1.24
Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother (2003) 1.24
Molecular characterization of erythromycin-resistant clinical isolates of the four major antimicrobial-resistant Spanish clones of Streptococcus pneumoniae (Spain23F-1, Spain6B-2, Spain9V-3, and Spain14-5). Microb Drug Resist (2003) 1.20
Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist (2004) 1.20
Incidence of mefA and mefE genes in viridans group streptococci. Antimicrob Agents Chemother (1999) 1.13
Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J Clin Microbiol (2003) 1.09
Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae. Antimicrob Agents Chemother (2004) 1.09
Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother (2003) 1.03
Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain. Antimicrob Agents Chemother (2005) 0.95
Genetic elements carrying macrolide efflux genes in streptococci. Curr Drug Targets Infect Disord (2004) 0.94
[Prevention of perinatal group B streptococcal disease. Spanish revised guidelines. The Spanish Society of Obstetrics and Gynecology, The Spanish Society of Neonatology, The Spanish Society of Infectious Diseases and Clinical Microbiology, The Spanish Society of Chemotherapy, and the The Spanish Society of Family and Community Medicine]. Enferm Infecc Microbiol Clin (2003) 0.83
Human bocavirus, a respiratory and enteric virus. Emerg Infect Dis (2007) 2.27
Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents. Antimicrob Agents Chemother (2011) 1.52
Molecular characterization of Staphylococcus aureus carrying the panton-valentine leucocidin genes in northern Spain. J Infect (2011) 1.49
Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain. Emerg Infect Dis (2004) 1.38
Human metapneumovirus and community-acquired respiratory illness in children. Emerg Infect Dis (2003) 1.27
Molecular characterization of erythromycin-resistant clinical isolates of the four major antimicrobial-resistant Spanish clones of Streptococcus pneumoniae (Spain23F-1, Spain6B-2, Spain9V-3, and Spain14-5). Microb Drug Resist (2003) 1.20
Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. Emerg Infect Dis (2009) 1.19
Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis. Lancet (2002) 1.13
Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother (2007) 1.12
In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease. Clin Infect Dis (2005) 0.97
Human metapneumovirus and chronic obstructive pulmonary disease. Emerg Infect Dis (2004) 0.96
Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003. Antimicrob Agents Chemother (2004) 0.96
Two outbreaks of Listeria monocytogenes infection, Northern Spain. Emerg Infect Dis (2014) 0.96
Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the results. BMC Infect Dis (2012) 0.91
[III Spanish Consensus Conference on Helicobacter pylori infection]. Gastroenterol Hepatol (2013) 0.88
Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples. J Antimicrob Chemother (2011) 0.88
Streptococcus pyogenes emm-types in northern Spain; population dynamics over a 7-year period. J Infect (2013) 0.87
Spread of a highly mucoid Streptococcus pyogenes emm3/ST15 clone. BMC Infect Dis (2010) 0.86
Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies. PLoS One (2012) 0.86
Molecular epidemiology and variants of the multidrug-resistant Streptococcus pneumoniae Spain14-5 international clone among Spanish clinical isolates. J Antimicrob Chemother (2006) 0.84
A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia. J Antimicrob Chemother (2006) 0.84
High rate of fecal carriage of extended-spectrum-β-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, northern Spain. Antimicrob Agents Chemother (2014) 0.83
Characterisation of the main clones of Streptococcus pyogenes carrying the ermA (subclass TR) gene in Spain. Int J Antimicrob Agents (2006) 0.83
Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain. Emerg Infect Dis (2014) 0.82
Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008). PLoS One (2009) 0.81
Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003. J Med Microbiol (2005) 0.80
Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae isolates from elderly patients with pneumonia and acute exacerbation of chronic obstructive pulmonary disease. Antimicrob Agents Chemother (2011) 0.80
Autochthonous Nocardia cerradoensis Infection in Humans, Spain, 2011 and 2014. Emerg Infect Dis (2016) 0.80
Trichophyton rubrum syndrome: the tip of the iceberg and a preventable outcome. Mycoses (2009) 0.78
[Dermatophytosis with concurrent lesions in distant locations. Prognostic and therapeutic significance]. Enferm Infecc Microbiol Clin (2005) 0.78
Decline and rise of the antimicrobial susceptibility of Streptococcus pneumoniae isolated from middle ear fluid in children: influence of changes in circulating serotypes. Antimicrob Agents Chemother (2012) 0.77
Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates. J Infect (2011) 0.77
[Seroconversion and seroreversion rate of Helicobacter pylori infection in women attended at hospital for delivery]. Med Clin (Barc) (2003) 0.77
Vitamin D and tuberculosis incidence in Spain. Am J Respir Crit Care Med (2008) 0.77
Yersinia enterocolitica O:3 infection of a prosthetic knee joint related to recurrent hemarthrosis. Scand J Infect Dis (2002) 0.77
In vitro activities of retapamulin and 16 other antimicrobial agents against recently obtained Streptococcus pyogenes isolates. Antimicrob Agents Chemother (2011) 0.76
Recommendations for vaccination against pneumococcus in kidney patients in Spain. Nefrologia (2014) 0.76
[Tetracyclines, sulfonamides, and metronidazole]. Enferm Infecc Microbiol Clin (2010) 0.76
[Recommendations for selecting antimicrobial agents for in vitro susceptibility studies using automatic and semiautomatic systems]. Enferm Infecc Microbiol Clin (2007) 0.75
[Molecular biology in the diagnosis of acute bacterial infection of the respiratory tract]. Enferm Infecc Microbiol Clin (2008) 0.75
[2009 pandemic influenza A (H1N1), six months experience]. Med Clin (Barc) (2010) 0.75
[Low levels of drug resistance in Mycobacterium tuberculosis strains isolated in Guipuzkoa (1993-2001)]. Enferm Infecc Microbiol Clin (2002) 0.75